CX Institutional’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Hold |
12,196
| – | – | 0.04% | 267 |
|
|
2025
Q1 | $989K | Hold |
12,196
| – | – | 0.04% | 272 |
|
|
2024
Q4 | $1.1M | Buy |
12,196
+196
| +2% | +$17.7K | 0.04% | 243 |
|
|
2024
Q3 | $1.19M | Hold |
12,000
| – | – | 0.05% | 262 |
|
|
2024
Q2 | $1.11M | Hold |
12,000
| – | – | 0.05% | 267 |
|
|
2024
Q1 | $1.14M | Hold |
12,000
| – | – | 0.05% | 265 |
|
|
2023
Q4 | $1.07M | Hold |
12,000
| – | – | 0.06% | 248 |
|
|
2023
Q3 | $876K | Hold |
12,000
| – | – | 0.05% | 268 |
|
|
2023
Q2 | $998K | Sell |
12,000
-350
| -3% | -$29.1K | 0.05% | 279 |
|
|
2023
Q1 | $952K | Hold |
12,350
| – | – | 0.05% | 280 |
|
|
2022
Q4 | $1.03M | Hold |
12,350
| – | – | 0.06% | 273 |
|
|
2022
Q3 | $980K | Sell |
12,350
-166
| -1% | -$13.2K | 0.07% | 266 |
|
|
2022
Q2 | $929K | Buy |
12,516
+166
| +1% | +$12.3K | 0.07% | 248 |
|
|
2022
Q1 | $1.11M | Hold |
12,350
| – | – | 0.09% | 208 |
|
|
2021
Q4 | $1.38M | Hold |
12,350
| – | – | 0.11% | 176 |
|
|
2021
Q3 | $1.55M | Hold |
12,350
| – | – | 0.13% | 174 |
|
|
2021
Q2 | $1.67M | Hold |
12,350
| – | – | 0.14% | 172 |
|
|
2021
Q1 | $1.68M | Hold |
12,350
| – | – | 0.15% | 169 |
|
|
2020
Q4 | $1.74M | Hold |
12,350
| – | – | 0.17% | 165 |
|
|
2020
Q3 | $1.38M | Buy |
12,350
+350
| +3% | +$39K | 0.15% | 159 |
|
|
2020
Q2 | $1.34M | Hold |
12,000
| – | – | 0.18% | 136 |
|
|
2020
Q1 | $929K | Hold |
12,000
| – | – | 0.15% | 138 |
|
|
2019
Q4 | $1.14M | Hold |
12,000
| – | – | 0.2% | 105 |
|
|
2019
Q3 | $915K | Hold |
12,000
| – | – | 0.15% | 136 |
|
|
2019
Q2 | $1.05M | Hold |
12,000
| – | – | 0.17% | 125 |
|
|
2019
Q1 | $1.09M | Hold |
12,000
| – | – | 0.19% | 123 |
|
|
2018
Q4 | $861K | Buy |
+12,000
| New | +$861K | 0.18% | 97 |
|